These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10916096)

  • 1. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
    Wolf WC; Yoshida H; Agata J; Chao L; Chao J
    Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
    Chao J; Zhang JJ; Lin KF; Chao L
    Hum Gene Ther; 1998 Jan; 9(1):21-31. PubMed ID: 9458239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats.
    Chao J; Zhang JJ; Lin KF; Chao L
    Kidney Int; 1998 Oct; 54(4):1250-60. PubMed ID: 9767541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
    Zhang JJ; Bledsoe G; Kato K; Chao L; Chao J
    Kidney Int; 2004 Aug; 66(2):722-32. PubMed ID: 15253727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats.
    Murakami H; Yayama K; Chao L; Chao J
    Kidney Int; 1998 May; 53(5):1305-13. PubMed ID: 9573546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
    Xia CF; Bledsoe G; Chao L; Chao J
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F622-31. PubMed ID: 15886273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats.
    Dobrzynski E; Yoshida H; Chao J; Chao L
    Immunopharmacology; 1999 Oct; 44(1-2):57-65. PubMed ID: 10604525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats.
    Zhang JJ; Yoshida H; Chao L; Chao J
    Hum Gene Ther; 2000 Sep; 11(13):1817-27. PubMed ID: 10986555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats.
    Jin L; Zhang JJ; Chao L; Chao J
    Hum Gene Ther; 1997 Oct; 8(15):1753-61. PubMed ID: 9358025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats.
    Yayama K; Wang C; Chao L; Chao J
    Hypertension; 1998 May; 31(5):1104-10. PubMed ID: 9576121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats.
    Zhang JJ; Chao L; Chao J
    Stroke; 1999 Sep; 30(9):1925-31; discussion 1931-2. PubMed ID: 10471446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction.
    Agata J; Chao L; Chao J
    Hypertension; 2002 Nov; 40(5):653-9. PubMed ID: 12411458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.
    Bledsoe G; Shen B; Yao Y; Zhang JJ; Chao L; Chao J
    Hum Gene Ther; 2006 May; 17(5):545-55. PubMed ID: 16716111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases.
    Chao J; Chao L
    Pharmacol Res; 1997 Jun; 35(6):517-22. PubMed ID: 9356201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tissue kallikrein attenuates hypertension and secretes into circulation and urine after intramuscular gene delivery in hypertensive rats.
    Zhang JJ; Wang C; Lin KF; Chao L; Chao J
    Clin Exp Hypertens; 1999 Oct; 21(7):1145-60. PubMed ID: 10513833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice.
    Emanueli C; Salis MB; Chao J; Chao L; Agata J; Lin KF; Munaò A; Straino S; Minasi A; Capogrossi MC; Madeddu P
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1459-66. PubMed ID: 10845858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
    Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
    Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats.
    Tu L; Xu X; Wan H; Zhou C; Deng J; Xu G; Xiao X; Chen Y; Edin ML; Voltz JW; Zeldin DC; Wang DW
    Hum Gene Ther; 2008 Apr; 19(4):318-30. PubMed ID: 18402547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury.
    Chao J; Kato K; Zhang JJ; Dobrzynski E; Wang C; Agata J; Chao L
    Peptides; 2001 Nov; 22(11):1731-7. PubMed ID: 11754958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries.
    Wang T; Li H; Zhao C; Chen C; Li J; Chao J; Chao L; Xiao X; Wang DW
    Gene Ther; 2004 Sep; 11(17):1342-50. PubMed ID: 15175642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.